{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:26:19Z","timestamp":1791325579309,"version":"4.3.1"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI142785, U19 AI109711"],"award-info":[{"award-number":["U19 AI142785, U19 AI109711"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Monoclonal antibodies (mAbs) have proven effective for the treatment of ebolavirus infection in humans, with two mAb-based drugs Inmazeb\u2122 and Ebanga\u2122 receiving FDA approval in 2020. While these drugs represent a major advance in the field of filoviral therapeutics, they are composed of antibodies with single-species specificity for Zaire ebolavirus. The Ebolavirus genus includes five additional species, two of which, Bundibugyo ebolavirus and Sudan ebolavirus, have caused severe disease and significant outbreaks in the past. There are several recently identified broadly neutralizing ebolavirus antibodies, including some in the clinical development pipeline, that have demonstrated broad protection in preclinical studies. In this review, we describe how structural biology has illuminated the molecular basis of broad ebolavirus neutralization, including details of common antigenic sites of vulnerability on the glycoprotein surface. We begin with a discussion outlining the history of monoclonal antibody therapeutics for ebolaviruses, with an emphasis on how structural biology has contributed to these efforts. Next, we highlight key structural studies that have advanced our understanding of ebolavirus glycoprotein structures and mechanisms of antibody-mediated neutralization. Finally, we offer examples of how structural biology has contributed to advances in anti-viral medicines and discuss what opportunities the future holds, including rationally designed next-generation therapeutics with increased potency, breadth, and specificity against ebolaviruses.<\/jats:p>","DOI":"10.3389\/fimmu.2021.808047","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:32:15Z","timestamp":1641774735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development"],"prefix":"10.3389","volume":"12","author":[{"given":"Charles D.","family":"Murin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Gilchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"B1","first-page":"1","article-title":"The Aetiology of an Unknown Human Infection Transmitted by Monkeys (Preliminary Communication)","volume":"13","author":"Siegert","year":"1968","journal-title":"Ger Med Mon"},{"key":"B2","first-page":"161","article-title":"Biological and Morphological Characteristics of the \u201cHemorrhagic Fever\u201d Virus Occurring in Germany","volume":"80","author":"Kunz","year":"1968","journal-title":"Wien Klin Wochenschr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.160.3830.888","article-title":"Agent of Disease Contracted From Green Monkeys","volume":"160","author":"Kissling","year":"1968","journal-title":"Science"},{"key":"B4","article-title":"Ebola Haemorrhagic Fever in Sudan, 1976","volume":"56","year":"1978","journal-title":"B World Health Organ"},{"key":"B5","article-title":"Ebola Haemorrhagic Fever in Zaire, 1976","volume":"56","year":"1978"},{"key":"B6","unstructured":"FDA Approves Treatment for Ebola Virus | FDA"},{"key":"B7","unstructured":"FDA Approves First Treatment for Ebola Virus | FDA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1086\/514115","article-title":"Development of a Humanized Monoclonal Antibody (MEDI-493) With Potent In Vitro and In Vivo Activity Against Respiratory Syncytial Virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"B10","article-title":"Ibalizumab, A CD4-Specific mAb to Inhibit HIV-1 Infection","volume":"2000","author":"Dimitrov","year":"2007","journal-title":"Curr Opin Investigat Drugs Lond Engl"},{"key":"B11","unstructured":"Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 | FDA"},{"key":"B12","unstructured":"Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19 | FDA"},{"key":"B13","unstructured":"Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for\u00a0Pre-exposure Prevention of COVID-19 in Certain Individuals [Press\u00a0release]2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/s41467-021-22132-0","article-title":"Combination Therapy Protects Macaques Against Advanced Marburg Virus Disease","volume":"12","author":"Cross","year":"2021","journal-title":"Nat Commun"},{"key":"B15","unstructured":"Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy235","article-title":"Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection","volume":"218","author":"Marzi","year":"2018","journal-title":"J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"eaai8711","DOI":"10.1126\/scitranslmed.aai8711","article-title":"Therapeutic Treatment of Marburg and Ravn Virus Infection in Nonhuman Primates With a Human Monoclonal Antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci Transl Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1007836","DOI":"10.1371\/journal.ppat.1007836","article-title":"A Broadly Neutralizing Germline-Like Human Monoclonal Antibody Against Dengue Virus Envelope Domain III","volume":"15","author":"Hu","year":"2019","journal-title":"PloS Pathog"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41541-016-0003-3","article-title":"A Potent Neutralizing Antibody With Therapeutic Potential Against All Four Serotypes of Dengue Virus","volume":"2","author":"Xu","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.abc0476","article-title":"Structural Basis for Antibody Inhibition of Flavivirus NS1\u2013Triggered Endothelial Dysfunction","volume":"371","author":"Biering","year":"2021","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0043-x","article-title":"Advances in the Research and Development of Therapeutic Antibodies Against the Zika Virus","volume":"16","author":"Jiang","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.06.011","article-title":"Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects Against Zika Virus Infection","volume":"18","author":"Erasmus","year":"2020","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01049-17","article-title":"Monoclonal Antibodies Against Zika Virus: Therapeutics and Their Implications for Vaccine Design","volume":"91","year":"2017","journal-title":"J Virol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12506","article-title":"HIV Antibodies for Treatment of HIV Infection","volume":"275","author":"Margolis","year":"2017","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30174-7","article-title":"Preventive and Therapeutic Features of Broadly Neutralising Monoclonal Antibodies Against HIV-1","volume":"5","author":"Jaworski","year":"2018","journal-title":"Lancet HIV"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1363","article-title":"The Growth and Potential of Human Antiviral Monoclonal Antibody Therapeutics","volume":"25","author":"Marasco","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104562","DOI":"10.1016\/j.antiviral.2019.104562","article-title":"New Antibody-Based Prevention and Treatment Options for Influenza","volume":"170","author":"Sedeyn","year":"2019","journal-title":"Antivir Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.051","article-title":"Safety and Efficacy of Monoclonal Antibody VIS410 in Adults With Uncomplicated Influenza A Infection: Results From a Randomized, Double-Blind, Phase-2, Placebo-Controlled Study","volume":"40","author":"Hershberger","year":"2019","journal-title":"Ebiomedicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal Influenza Virus Vaccines and Therapeutic Antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing Monoclonal Antibodies for Treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1105099","article-title":"\u00dcber Eine Durch Cercopithecus Aethiops \u00dcbertragene Infektionskrankheit","volume":"93","author":"Stille","year":"1968","journal-title":"Dmw - Deutsche Medizinische Wochenschrift"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-01593-3_2","article-title":"Clinical Course and Prognosis of Marburg Virus (\u201cGreen-Monkey\u201d) Disease","volume-title":"Marburg Virus Disease","author":"Stille","year":"1971"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-01593-3_3","article-title":"Clinical Picture of Two Patients Infected by the Marburg Vervet Virus","author":"Todorovitch","year":"1971","journal-title":"Marburg Virus Disease"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1093\/infdis\/jiw207","article-title":"Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013\u20132016","volume":"214","author":"Breman","year":"2016","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","article-title":"A Case of Ebola Virus Infection","volume":"2","author":"Emond","year":"1977","journal-title":"Brit Med J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1086\/514298","article-title":"Treatment of Ebola Hemorrhagic Fever With Blood Transfusions From Convalescent Patients","volume":"179","author":"Mupapa","year":"1999","journal-title":"J Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1086\/514310","article-title":"Evaluation of Immune Globulin and Recombinant Interferon-\u03b12b for Treatment of Experimental Ebola Virus Infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-7482-1_12","article-title":"Passive Immunization of Ebola Virus-Infected Cynomolgus Monkeys With Immunoglobulin From Hyperimmune Horses","author":"Jahrling","year":"","journal-title":"Imported Virus Infections. Archives of Virology Supplement II, vol 11"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection","volume":"73","author":"Maruyama","year":"1999","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PloS Pathog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola Virus Glycoprotein Bound to an Antibody From a Human Survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody-Mediated Neutralization of Ebola Virus Can Occur by Two Distinct Mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure Antibody Prophylaxis Protects Nonhuman Primates From Filovirus Disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.08.008","article-title":"Characterization of Zaire Ebolavirus Glycoprotein-Specific Monoclonal Antibodies","volume":"141","author":"Qiu","year":"2011","journal-title":"Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1575","DOI":"10.1371\/journal.pntd.0001575","article-title":"Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs From Lethal Ebola Virus Infection","volume":"6","author":"Qiu","year":"2012","journal-title":"PloS Negl Trop D"},{"key":"B46","doi-asserted-by":"publisher","first-page":"138ra81","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful Treatment of Ebola Virus\u2013Infected Cynomolgus Macaques With Monoclonal Antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed Treatment of Ebola Virus Infection With Plant-Derived Monoclonal Antibodies Provides Protection in Rhesus Macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of Advanced Ebola Virus Disease in Nonhuman Primates With ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of Protective Antibodies Reveal Sites of Vulnerability on Ebola Virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604330","article-title":"A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2150","article-title":"A Shared Structural Solution for Neutralizing Ebolaviruses","volume":"18","author":"Dias","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/v4040447","article-title":"Structural Basis for Differential Neutralization of Ebolaviruses","volume":"4","author":"Bale","year":"2012","journal-title":"Viruses"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.041","article-title":"Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody","volume":"160","author":"Hashiguchi","year":"2015","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1107\/S0907444909032314","article-title":"Techniques and Tactics Used in Determining the Structure of the Trimeric Ebola Virus Glycoprotein","volume":"65","author":"Lee","year":"2009","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.10.017","article-title":"Complex of a Protective Antibody With Its Ebola Virus GP Peptide Epitope: Unusual Features of a V\u03bbx Light Chain","volume":"375","author":"Lee","year":"2008","journal-title":"J Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05549-11","article-title":"Structure of an Antibody in Complex With Its Mucin Domain Linear Epitope That Is Protective Against Ebola Virus","volume":"86","author":"Olal","year":"2012","journal-title":"J Virol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00870-14","article-title":"Spatial Localization of the Ebola Virus Glycoprotein Mucin-Like Domain Determined by Cryo-Electron Tomography","volume":"88","author":"Tran","year":"2014","journal-title":"J Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00406-16","article-title":"Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry","volume":"90","author":"Tran","year":"2016","journal-title":"J Virol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2015.01.031","article-title":"Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus","volume":"160","author":"Flyak","year":"2015","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"AID","DOI":"10.1128\/9781555817411.ch8","article-title":"Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies","volume":"3","author":"Smith","year":"2015","journal-title":"Microbiol Spectr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5788","article-title":"Isolation of Potent Neutralizing Antibodies From a Survivor of the 2014 Ebola Virus Outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02172-15","article-title":"Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes Within Filovirus Glycoprotein","volume":"90","author":"Keck","year":"2016","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic Analysis of Monoclonal Antibodies Against Ebola Virus GP Defines Features That Contribute to Protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates","volume":"218","author":"Pascal","year":"2018","journal-title":"J Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2018.06.018","article-title":"Multifunctional Pan-Ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein","volume":"49","author":"Gilchuk","year":"2018","journal-title":"Immunity"},{"key":"B67","doi-asserted-by":"publisher","first-page":"aad5224","DOI":"10.1126\/science.aad5224","article-title":"Protective Monotherapy Against Lethal Ebola Virus Infection by a Potently Neutralizing Antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1742457","DOI":"10.1080\/19420862.2020.1742457","article-title":"Potent Neutralizing Monoclonal Antibodies Against Ebola Virus Isolated From Vaccinated Donors","volume":"12","author":"Fan","year":"2020","journal-title":"Mabs"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2018.1473698","article-title":"The Vesicular Stomatitis Virus-Based Ebola Virus Vaccine: From Concept to Clinical Trials","volume":"14","author":"Suder","year":"2018","journal-title":"Hum Vacc Immunother"},{"key":"B70","doi-asserted-by":"publisher","first-page":"16128","DOI":"10.1038\/nmicrobiol.2016.128","article-title":"Structures of Ebola Virus GP and sGP in Complex With Therapeutic Antibodies","volume":"1","author":"Pallesen","year":"2016","journal-title":"Nat Microbiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01674-18","article-title":"Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody Against a Conserved, Yet Cryptic Epitope","volume":"9","author":"West","year":"2018","journal-title":"Mbio"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.celrep.2018.08.009","article-title":"Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop","volume":"24","author":"Murin","year":"2018","journal-title":"Cell Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-019-0191-4","article-title":"Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody","volume":"26","author":"West","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies From a Human Survivor Define Sites of Vulnerability for Broad Protection Against Ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0392-y","article-title":"Antibody Responses to Viral Infections: A Structural Perspective Across Three Different Enveloped Viruses","volume":"4","author":"Murin","year":"2019","journal-title":"Nat Microbiol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid Isolation and Profiling of a Diverse Panel of Human Monoclonal Antibodies Targeting the SARS-CoV-2 Spike Protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, A Neutralizing Antibody Cocktail, in Outpatients With Covid-19","volume":"384","author":"Weinreich","year":"2020","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251652","article-title":"The Resolution Revolution","volume":"343","author":"K\u00fchlbrandt","year":"2014","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01130-6","article-title":"Understanding the Invisible Hands of Sample Preparation for cryo-EM","volume":"18","author":"Weissenberger","year":"2021","journal-title":"Nat Methods"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer","volume":"342","author":"Lyumkis","year":"2013","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/science.1245625","article-title":"Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer","volume":"342","author":"Julien","year":"2013","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2017.22738","article-title":"Cryo-Electron Microscopy Wins Chemistry Nobel","volume":"550","author":"Cressey","year":"2017","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"aad6117","DOI":"10.1126\/science.aad6117","article-title":"Structural and Molecular Basis for Ebola Virus Neutralization by Protective Human Antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nature12966","article-title":"Proof of Principle for Epitope-Focused Vaccine Design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","article-title":"Structure-Based Vaccine Antigen Design","volume":"70","author":"Graham","year":"2019","journal-title":"Annu Rev Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"101428","DOI":"10.1016\/j.smim.2020.101428","article-title":"Antibody-Guided Structure-Based Vaccines","volume":"50","author":"Kwong","year":"2020","journal-title":"Semin Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola Virus Glycoprotein by the Proprotein Convertase Furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.2.1419-1426.1999","article-title":"Endoproteolytic Processing of the Ebola Virus Envelope Glycoprotein: Cleavage is Not Required for Function","volume":"73","author":"Wool-Lewis","year":"1999","journal-title":"J Virol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-75474-1_5","article-title":"Proteolytic Processing of Filovirus Glycoproteins","author":"Volchkov","year":"","journal-title":"Activation of Viruses by Host Proteases"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nature10380","article-title":"Small Molecule Inhibitors Reveal Niemann-Pick C1 Is Essential for Ebolavirus Infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nature18615","article-title":"Toremifene Interacts With and Destabilizes the Ebola Virus Glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"B92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.chom.2017.12.003","article-title":"The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding","volume":"23","author":"King","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B93","doi-asserted-by":"publisher","first-page":"108984","DOI":"10.1016\/j.celrep.2021.108984","article-title":"Convergence of a Common Solution for Broad Ebolavirus Neutralization by Glycan Cap-Directed Human Antibodies","volume":"35","author":"Murin","year":"2021","journal-title":"Cell Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.03.049","article-title":"Cooperativity Enables Non-Neutralizing Antibodies to Neutralize Ebolavirus","volume":"19","author":"Howell","year":"2017","journal-title":"Cell Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02154-15","article-title":"Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies","volume":"7","author":"Bornholdt","year":"2016","journal-title":"Mbio"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nature10348","article-title":"Ebola Virus Entry Requires the Cholesterol Transporter Niemann\u2013Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.53","article-title":"Ebola Virus Entry Requires the Host-Programmed Recognition of an Intracellular Receptor","volume":"31","author":"Miller","year":"2012","journal-title":"EMBO J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.022","article-title":"Structural Insights Into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection","volume":"165","author":"Gong","year":"2016","journal-title":"Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.026","article-title":"Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope Within the Glycoprotein Receptor-Binding Site","volume":"15","author":"Howell","year":"2016","journal-title":"Cell Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01635","article-title":"Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity","volume":"11","author":"Murin","year":"2020","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1016\/j.cell.2021.09.035","article-title":"Pan-Ebolavirus Protective Therapy by Two Multifunctional Human Antibodies","volume":"184","author":"Gilchuk","year":"2021","journal-title":"Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e3000139","DOI":"10.1371\/journal.pbio.3000139","article-title":"Potent Anti-Influenza H7 Human Monoclonal Antibody Induces Separation of Hemagglutinin Receptor-Binding Head Domains","volume":"17","author":"Turner","year":"2019","journal-title":"PloS Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136032","article-title":"Anti\u2013influenza H7 Human Antibody Targets Antigenic Site in Hemagglutinin Head Domain Interface","volume":"130","author":"Dong","year":"2020","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e146791","DOI":"10.1172\/jci146791","article-title":"Canonical Features of Human Antibodies Recognizing the Influenza Hemagglutinin Trimer Interface","volume":"131","author":"Zost","year":"2021","journal-title":"J Clin Invest"},{"key":"B107","doi-asserted-by":"publisher","first-page":"eabh2791","DOI":"10.1126\/sciadv.abh2791","article-title":"Disassembly of HIV Envelope Glycoprotein Trimer Immunogens Is Driven by Antibodies Elicited via Immunization","volume":"7","author":"Turner","year":"2021","journal-title":"Sci Adv"},{"key":"B108","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.chom.2020.06.010","article-title":"Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/science.1110656","article-title":"Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J\u00a0Virol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","article-title":"Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability","volume":"169","author":"Zhao","year":"2017","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/s41467-018-06113-4","article-title":"Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein Fusion Loop","volume":"9","author":"Janus","year":"2018","journal-title":"Nat Commun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a Human Antibody Cocktail That Deploys Multiple Functions to Confer Pan-Ebolavirus Protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.2662","article-title":"Core Structure of the Envelope Glycoprotein GP2 From Ebola Virus at 1.9-\u00c5 Resolution","volume":"96","author":"Malashkevich","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus Glycoprotein Structure and Mechanism of Entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","article-title":"A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates","volume":"25","author":"Bornholdt","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708052114","article-title":"Structure of the Ebola Virus Envelope Protein MPER\/TM Domain and its Interaction With the Fusion Loop Explains Their Fusion Activity","volume":"114","author":"Lee","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41467-019-09732-7","article-title":"Cross-Reactive Neutralizing Human Survivor Monoclonal Antibody BDBV223 Targets the Ebolavirus Stalk","volume":"10","author":"King","year":"2019","journal-title":"Nat Commun"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced Sensitivity of SARS-CoV-2 Variant Delta to Antibody Neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.lanepe.2021.100164","article-title":"Emergence of the E484K Mutation in SARS-COV-2-Infected Immunocompromised Patients Treated With Bamlanivimab in Germany","volume":"8","author":"Jensen","year":"2021","journal-title":"Lancet Regional Heal - Europe"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human Monoclonal Antibody Combination Against SARS Coronavirus: Synergy and Coverage of Escape Mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PloS Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7061854","article-title":"Monoclonal Antibody Combinations That Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs","volume":"7","author":"Diamant","year":"2015","journal-title":"Toxins"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01446-18","article-title":"Neutralization Synergy Between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies Against HIV","volume":"93","author":"Zhang","year":"2019","journal-title":"J Virol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718441115","article-title":"Synergistic Anti-HCV Broadly Neutralizing Human Monoclonal Antibodies With Independent Mechanisms","volume":"115","author":"Mankowski","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag3267","article-title":"A \u201cTrojan Horse\u201d Bispecific-Antibody Strategy for Broad Protection Against Ebolaviruses","volume":"354","author":"Wec","year":"2016","journal-title":"Science"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729851","article-title":"Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity","volume":"12","author":"Wirchnianski","year":"2021","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited During HIV-1 BG505 Envelope Trimer Immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"key":"B128","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1016\/j.celrep.2020.02.061","article-title":"Mapping Polyclonal Antibody Responses in Non-Human Primates Vaccinated With HIV Env Trimer Subunit Vaccines","volume":"30","author":"Nogal","year":"2020","journal-title":"Cell Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"108682","DOI":"10.1016\/j.celrep.2020.108682","article-title":"Polyclonal Epitope Mapping Reveals Temporal Dynamics and Diversity of Human Antibody Responses to H5N1 Vaccination","volume":"34","author":"Han","year":"2021","journal-title":"Cell Rep"},{"key":"B130","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1038\/s41467-021-25087-4","article-title":"Polyclonal Antibody Responses to HIV Env Immunogens Resolved Using cryoEM","volume":"12","author":"Antanasijevic","year":"2021","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.13.439712","article-title":"From Structure to Sequence: Identification of Polyclonal Antibody Families Using cryoEM","volume":"2021","author":"Antanasijevic","year":"2021","journal-title":"Biorxiv"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0688-0","article-title":"MINFLUX Nanoscopy Delivers 3D Multicolor Nanometer Resolution in Cells","volume":"17","author":"Gwosch","year":"2020","journal-title":"Nat Methods"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0079-y","article-title":"Calling Cell Biologists to Try cryo-ET","volume":"15","author":"Marx","year":"2018","journal-title":"Nat Methods"},{"key":"B134","first-page":"1","article-title":"Cellular Electron Cryotomography: Toward Structural Biology In Situ","volume":"86","author":"Oikonomou","year":"2016","journal-title":"Annu Rev Biochem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.808047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:32:27Z","timestamp":1641774747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.808047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":134,"alternative-id":["10.3389\/fimmu.2021.808047"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.808047","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"article-number":"808047"}}